Egros Fabrice
SEC CIK 1597085 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| SNDX | Syndax Pharmaceuticals Inc | Dir | 32.0K | — | $499.2K | 5 | 2021-08-18 | 2022-02-02 |
Most active insiders at SNDX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Metzger Michael A | CEO, Dir | — | $1.43M |
| 2 | Botwood Nicholas A.J. | CMO, Head of R, D | — | $1.18M |
| 3 | Goldan Keith A. | CFO | — | $137.0K |
| 4 | Rizo Aleksandra | Dir | — | — |
| 5 | Jarrett Jennifer | Dir | — | — |
| 6 | Huber Martin H. Jr. | Dir | — | — |
| 7 | Legault Pierre | Dir | — | — |
| 8 | Katkin Keith | Dir | — | — |
| 9 | Podlesak Dennis | Dir | — | — |
Egros Fabrice made no open-market trades at SNDX in the last 12 months.
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-02-03 | 2022-02-02 | SNDX | Syndax Pharmaceuticals Inc | Egros Fabrice | Dir | A - Grant | $0.00 | +16.0K | 32.0K | +100% | $0 | |
| DM | 2021-11-19 | 2021-11-18 | SNDX | Syndax Pharmaceuticals Inc | Egros Fabrice | Dir | S - Sale+OE | $18.03 | -14.0K | 16.0K | -47% | -$253.0K |
| DM | 2021-11-19 | 2021-11-18 | SNDX | Syndax Pharmaceuticals Inc | Egros Fabrice | Dir | M - OptEx | $8.93 | +14.0K | 30.0K | +88% | +$125.3K |
| D | 2021-08-20 | 2021-08-18 | SNDX | Syndax Pharmaceuticals Inc | Egros Fabrice | Dir | S - Sale+OE | $15.75 | -15.6K | 16.0K | -49% | -$246.3K |
| D | 2021-08-20 | 2021-08-18 | SNDX | Syndax Pharmaceuticals Inc | Egros Fabrice | Dir | M - OptEx | $7.88 | +15.6K | 31.6K | +98% | +$123.2K |
Purchase Sale Sale after option exercise All abbreviations